Mustang Bio’s gene therapy has tremendous potential to cure XSCID or Bubble Boy Disease based on study results from St. Jude

from Cell Culture Dish Podcast · host The Cell Culture Dish

In this podcast, we interviewed Dr. Manny Litchman, President and CEO, Mustang Bio and Dr. Knut Niss, Chief Technology Officer, Mustang Bio about the exciting study results for their gene therapy candidate to treat X-SCID, why this disease is a good fit for gene therapy and next steps.

Episode metadata supplied by the publisher feed · Published Jul 31, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

Mustang Bio’s gene therapy has tremendous potential to cure XSCID or Bubble Boy Disease based on study results from St. Jude

0:00 14:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cell Culture Dish Podcast?

This episode is 14 minutes long.

When was this Cell Culture Dish Podcast episode published?

This episode was published on July 31, 2019.

Can I download this Cell Culture Dish Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!